2024-02-15T15:07:36-06:00 2023-03-31 111986323 MARCUM LLP 1899 L STREET NW 850 WASHINGTON DC 20036 990 2022-04-01 366066325 AMERICAN GASTROENTEROLOGICAL ASSOCIATION INSTITUTE AMER 3016542055 4930 DEL RAY AVENUE BETHESDA MD 20814 CHRISTOPHER BLUHM VICE PRESIDENT, FINANCE 3016542055 2024-02-15 1 CHRISTOPHER BLUHM 999009999 1 AARON M FOX P01365820 2028225000 2024-02-15 0 AAL1 IAL1 2022 2023-04-26 12:10:37Z THOMAS SERENA 4930 DEL RAY AVENUE BETHESDA MD 20814 51065904 0 X GASTRO.ORG X 1937 DE TO CARRY OUT THE EDUCATIONAL, PRACTICE, AND RESEARCH INTERESTS PERTAINING TO GASTROENTEROLOGY. 13 10 123 152 420151 268082 4081463 2746974 24403511 20405109 2424853 1737809 145314 7220636 31055141 32110528 2344857 2894101 0 0 12344470 12502823 0 0 1205672 10188988 14607601 24878315 30004525 6176826 2106003 105553578 100783850 20430062 17770141 85123516 83013709 X THE PURPOSE OF AMERICAN GASTROENTEROLOGICAL ASSOCIATION INSTITUTE, INC. IS TO ADVANCE AND FOSTER THE DEVELOPMENT AND APPLICATION OF THE SCIENCE AND PRACTICE OF GASTROENTEROLOGY AND CLOSELY RELATED FIELDS OF STUDY, MEDICAL AND SCIENTIFIC BY PROVIDING LEADERSHIP AND AID IN ALL ASPECTS OF THIS FIELD, INCLUDING PATIENT CARE, RESEARCH, TEACHING, CONTINUING EDUCATION AND SCIENTIFIC COMMUNICATION, AND MATTERS OF NATIONAL HEALTH POLICY PERTAINING TO GASTROENTEROLOGY. 0 0 12239534 313721 4334060 EDUCATION - AGA IS THE HOME OF SOME OF THE HIGHEST QUALITY SCIENTIFIC AND CLINICAL KNOWLEDGE FOR GI CLINICIANS AND RESEARCHERS IN THE WORLD. 6664462 2513663 11823299 RESEARCH - THE AGA PUBLISHES SCIENTIFIC JOURNALS AND RAISES FUNDS TO SUPPORT YOUNG RESEARCHERS IN THE FIELD OF GASTROENTEROLOGY AND HEPATOLOGY. 2381291 43349 3181057 MEMBER SERVICES - THE AGA IMPROVES THE PROFESSIONAL LIVES OF THE GI COMMUNITY THROUGH ACCESS TO UNIQUE PROFESSIONAL EVENTS, COMMITTEE WORK, NETWORKING OPPORTUNITIES, AND SUBSCRIPTIONS TO ITS PREMIER JOURNALS: GASTROENTEROLOGY AND CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 779741 23368 PRACTICE - AGA INSTITUTE DEFINES OPTIMAL CLINICAL PRACTICE AND HELPS GASTROENTEROLOGISTS PROVIDE HIGH QUALITY, HIGH-VALUE CARE. 788063 646542 ADVOCACY 1567804 23368 646542 22853091 1 1 0 0 0 0 0 0 0 1 1 1 0 0 1 1 0 1 0 0 1 1 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 1 0 1 310 0 1 123 1 1 1 1 BD 0 0 0 0 0 0 0 0 0 0 X 13 10 0 0 0 0 1 1 0 1 1 0 0 0 1 1 1 1 1 1 1 1 1 AK AL AR AZ CA CO CT DC FL GA HI IL KS KY MA MD ME MI MN MO MS NC ND NH NJ NM NY OH OK OR PA RI SC TN UT VA WA WI WV X THOMAS SERENA 3016542055 4930 DEL RAY AVENUE BETHESDA MD 20814 JOHN M INADOMI MD AGAF IMMEDIATE PAST PRESIDENT 2.50 2.50 X X 32141 6750 0 JOHN M CARETHERS MD AGAF PRESIDENT 2.50 2.50 X X 34413 0 0 LAWRENCE KIM MD AGAF SECRETARY-TREASURER UNTIL 05/2022 2.50 2.50 X X 13875 0 0 JOHN ALLEN MD MBA AGAF SECRETARY-TREASURER AS OF 05/2022 2.50 2.50 X X 13875 0 0 MARIA T ABREU MD AGAF VICE PRESIDENT 2.50 2.50 X X 4400 0 0 DAVID A KATZKA MD AGAF COUNCILLOR UNTIL 05/22 2.50 2.50 X 2250 0 0 BARBARA JUNG MD AGAF PRESIDENT ELECT 2.50 2.50 X X 0 0 0 M BISHR OMARY MD PHD AGAF IMMEDIATE PAST PRESIDENT UNTIL 05/22 2.50 2.50 X X 0 0 0 KIM E BARRETT PHD AGAF COUNCILLOR 2.50 2.50 X 0 0 0 MICHAEL CAMILLERI MD AGAF COUNCILLOR 2.50 X 0 0 0 ANDREW T CHAN MD MPH AGAF COUNCILLOR 2.50 2.50 X 0 0 0 NICHOLAS O DAVIDSON MD DSC AGAF COUNCILLOR 2.50 2.50 X 0 0 0 NARESH T GUNARATNAM MD AGAF COUNCILLOR 2.50 2.50 X 0 0 0 MICHAEL L KOCHMAN MD AGAF COUNCILLOR UNTIL 05/22 2.50 2.50 X 0 0 0 LAWRENCE R KOSINSKI MD MBA AGAF COUNCILLOR 2.50 2.50 X 0 0 0 SHERYL A PFEIL MD AGAF COUNCILLOR 2.50 2.50 X 0 0 0 MICHAEL L WEINSTEIN MD AGAF COUNCILLOR 2.50 2.50 X 0 0 0 THOMAS SERENA CHIEF EXECUTIVE OFFICER 37.50 0.00 X 490617 0 38240 NANCY CHILL SR. VICE PRESIDENT 37.40 0.10 X 296278 792 34113 CHRISTOPHER BLUHM SR. VICE PRESIDENT 36.80 0.70 X 228539 4347 34136 JEFFREY SPRINGER VP, MARKETING 34.30 3.20 X 207995 19405 25803 ALISON KIM VP, RESEARCH & PUBLICATIONS 37.50 0.00 X 220898 0 31303 ELLEN SILVER VP, MEETINGS & CONVENTIONS 34.40 0.10 X 218845 636 31600 CHANTAL FREMONT VP, PRACTICE & QUALITY 37.50 0.00 X 214513 0 24354 KATHLEEN TEIXEIRA VP, ADVOCACY 1.80 35.70 X 9968 197702 30633 JESSICA DUNCAN VP, COMMUNICATIONS 35.30 2.20 X 210921 13145 7635 LYNN GRONE VP, ORGANIZATIONAL EFFECTIVENESS 37.50 0.00 X 188529 0 30282 LESLIE HAUVER VP, INFORMATION TECHNOLOGY 37.50 0.00 X 194904 0 14874 CELENA NUQUAY VP, CONSTITUENCY & GOVERNANCE 33.10 4.40 X 133583 17757 28911 MAURA DAVIS SR. DIR EDUCATION 37.40 0.10 X 143992 385 28886 SONYA SERRA SR. DIR CLINICAL RESEARCH 37.50 0.00 X 142478 0 28713 TIMOTHY SUMMERS SR. DIR FINANCE 35.00 2.50 X 121187 8656 28004 LESLIE NARRAMORE SR. DIR ADVOCACY 0.40 37.10 X 1426 132243 4324 RICARDO BLUM SR. DIR MARKETING 36.50 1.00 X 119076 3263 12363 3244703 405081 434174 15 0 1 0 KNIGHTEN HEALTH LLC 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 MEDICAL EDUCATION 1136397 PRACTICING CLINICIANS EXCHANGE LLC 12001 SUNRISE VALLEY DRIVE SUITE 3 RESTON VA 20191 MEDICAL EDUCATION 211758 METADOG DESIGN GROUP 2104 12TH PLACE NW WASHINGTON DC 20009 MEDICAL EDUCATION 158220 TWENTYFORTY DIGITAL LLC 11619 HITCHING POST LANE SUITE 200 NORTH BETHESDA MD 20852 MEDICAL EDUCATION 121375 CLINICAL CARE OPTIONS LLC 12001 SUNRISE VALLEY DRIVE SUITE 3 RESTON VA 20191 MEDICAL EDUCATION 117839 5 793790 1953184 49552 2746974 SPONSORSHIPS 900099 8937175 8937175 PUBLICATIONS 541800 3306275 2886124 420151 EDUCATIONAL CONFERENCE 900099 2758560 2758560 AGA MANAGEMENT 900099 2741494 2741494 DIGESTIVE DISEASE WEEK 900099 2661605 2661605 20405109 1904342 1904342 7125786 7125786 111425 0 111425 111425 111425 18788843 18955376 -166533 -166533 -166533 OTHER INCOME 900099 146872 146872 LOSS ON DISPOSAL 900099 -163447 -163447 -16575 32110528 20096383 420151 8847020 X 5000 5000 2826601 2826601 62500 62500 3012402 1988185 813349 210868 7494840 4950990 1979492 564358 514618 347008 131032 36578 785578 494142 238472 52964 695385 476650 167432 51303 154931 154931 138553 1488 123281 13784 81488 81488 177148 177148 5727176 5301051 317723 108402 397397 396255 29 1113 619466 507193 81082 31191 1003691 239830 757111 6750 294346 10855 283491 1236778 1036473 175776 24529 2318512 2142431 123682 52399 396601 254612 114150 27839 92582 92582 HONORARIA 1492324 1377162 115162 MISCELLANEOUS 182648 158744 12564 11340 MEMBERSHIP DUES 99302 59788 39170 344 TEMP STAFFING 86955 55179 20265 11511 107703 6023 101281 399 30004525 22853091 5945762 1205672 0 2985407 18097649 12018529 1661410 2340700 1857961 1966965 538825 603348 12639809 7888111 4992914 4751698 76649485 63999867 0 9929676 1755334 2187660 105553578 100783850 3824362 3643398 4380400 4568700 11658383 9072598 566917 485445 20430062 17770141 X 50926429 50124662 34197087 32889047 85123516 83013709 105553578 100783850 X 2106003 -4351713 135903 X 0 1 X 1 0 X 3619602 2234060 3323781 4081463 2746974 16005880 24645987 26674487 22521660 24135610 19984958 117962702 28265589 28908547 25845441 28217073 22731932 133968582 38906 46381 57577 73094 20530 236488 438132 4957981 5559873 2209 37116 10995311 477038 5004362 5617450 75303 57646 11231799 122736783 2174129 1832168 1581067 1366187 9141553 16095104 146519 118289 117142 158699 268082 808731 2320648 1950457 1698209 1524886 9409635 16903835 698015 122778 179200 37134 146872 1183999 31284252 30981782 27722850 29779093 32288439 152056416 0.80720 0.78100 0.11120 0.07450 X SCHEDULE A, PART III, LINE 12, EXPLANATION OF OTHER INCOME: OTHER INCOME - 2018 AMOUNT: $ 698,015. 2019 AMOUNT: $ 122,778. 2020 AMOUNT: $ 179,200. 2021 AMOUNT: $ 37,134. 2022 AMOUNT: $ 146,872. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 32235607 1240175 -1277339 1155324 31043119 33895391 961129 -645836 1975077 32235607 23287761 3025335 9215295 1633000 33895391 24484597 1063455 -2263450 -3159 23287761 25137062 616513 -126555 1142423 24484597 0.00000 0.96644 0.03356 0 0 2150000 2150000 8524205 6290998 2233207 533232 443408 89824 1432372 1153705 278667 4751698 IRONWOOD INT'L LTD. HEDGE FUND 3966334 F POINTER OFFSHORE HEDGE FUND 3478857 F HAMILTON LANE PRIVATE MARKETS OPPORT. FUND 630084 F NB SOF IV CAYMAN HOLDINGS LP 426402 F PREMIER TIGER GLOBAL PRIVATE INVEST. XV OFFSHORE LP 399306 F OAKTREE OPPORT. XI OFFSHORE FEEDER LP 397324 F INVESTMENT IN RX.HEALTH 250000 C BLACKSTONE SP FUND IX 213033 F STEPSTONE SECONDARY OPPORT. FUND V 168336 F 9929676 DEFERRED COMPENSATION LIABILITY 477195 DEPOSITS 8250 485445 X 27717570 -4351713 135903 -4215810 31933380 177148 177148 32110528 29827377 0 29827377 177148 177148 30004525 PART V, LINE 4: THE ORGANIZATION'S ENDOWMENT CONSISTS OF INDIVIDUAL FUNDS ESTABLISHED FOR AWARDS AND RELATED ACTIVITIES. PART X, LINE 2: AGA AND AGAI EVALUATED THEIR UNCERTAINTY IN INCOME TAXES FOR THE YEARS ENDED MARCH 31, 2023 AND 2022 AND DETERMINED THAT THERE WERE NO MATTERS THAT WOULD REQUIRE RECOGNITION IN THE CONSOLIDATED FINANCIAL STATEMENTS, OR THAT MAY HAVE ANY EFFECT ON THEIR TAX-EXEMPT STATUS; AND THERE ARE CURRENTLY NO EXAMINATIONS PENDING OR IN PROGRESS. PART XI, LINE 2D - OTHER ADJUSTMENTS: GRANT RECOVERIES 146,925. CHANGE IN VALUE OF DEFERRED COMPENSATION INVESTMENTS -11,022. 1 CENTRAL AMERICA AND THE CARIBBEAN - ANTIGUA & BARBUDA, ARUBA, BAHAMAS, 0 0 INVESTMENTS 9717644 EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA, 0 0 PROGRAM SERVICES EDITORIAL AND PROGRAM DEVELOPMENT SVCS 55988 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM 0 0 PROGRAM SERVICES EDITORIAL AND PROGRAM DEVELOPMENT SVCS 111422 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM 0 0 GRANTMAKING 750 NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES 0 0 PROGRAM SERVICES EDITORIAL AND PROGRAM DEVELOPMENT SVCS 206429 NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES 0 0 GRANTMAKING 61000 SOUTH AMERICA - ARGENTINA, BOLIVIA, BRAZIL, CHILE, COLUMBIA, ECUADOR, 0 0 PROGRAM SERVICES EDITORIAL AND PROGRAM DEVELOPMENT SVCS 4430 MIDDLE EAST AND NORTH AFRICA - ALGERIA, BAHRAIN, DJIBOUTI, EGYPT, 0 0 PROGRAM SERVICES EDITORIAL AND PROGRAM DEVELOPMENT SVCS 16500 EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA, 0 0 GRANTMAKING 750 0 0 0 0 0 0 10174163 750 10174913 NORTH AMERICA PROGRAM SUPPORT 30000 0 NORTH AMERICA PROGRAM SUPPORT 30000 0 2 1 0 0 0 0 0 PART I, LINE 2: GRANTS AND AWARDS ARE AWARDED AND MONITORED BASED ON A PROGRAM'S BUDGET AND GRANT STIPULATIONS, IF ANY. PROGRAM MANAGERS ARE RESPONSIBLE FOR MONITORING THE USE OF GRANT FUNDS. PART I, LINE 3: AGA INSITUTE REPORTED THE EXPENDITURES BASED ON THE ACCOUNTING METHOD USED IN ITS AUDITED FINANCIAL STATEMENTS WHICH IS ON AN ACCRUAL BASIS. PART III ACCOUNTING METHOD: 1 ABSTRACT AWARD IN EOSINOPHILIC GI 3 1500 AGA FELLOW ABSTRACT AWARD 15 8000 AGA PILOT RESEARCH AWARD 4 120000 AGA RESEARCH SCHOLAR AWARD (RSA) 5 1281270 AGA-TAKEDA RSA IN IBD 1 300000 AMAN AHMED FAMILY - SURF 9 49200 AMGEN FELLOW TO FACULTY TRANSITION AWD 1 130000 AMGEN PILOT AWD IN HEALTH DISPARITIES 1 30000 AUGUSTYN AWARD 1 40000 BEAUMONT 2 10000 BMS FELLOW-TO-FACULTY TRANSITION AWD 2 260000 BRISTOL MYERS PILOT IBD 1 30000 DISTINGUISHED ACHIEVEMT 1 5000 FOUNDATION EQUITY PROJECT AWARDS 5 32000 FRIEDENWALD MEDAL 1 5000 FUNDERBURG AWARD 1 100000 GASTRIC CANCER FOUND. RES. AWD 1 300000 GRG-GASTRO RESEARCH GROUP 1 1000 HARVEY YOUNG FND GUTS SCHOLAR 15 39000 INVESTING IN THE FUTURE IBD 52 10450 J&J PILOT AWD IN HEALTH DISPARITIES 2 60000 RUSTGI AWARD FUND 2 1500 STUDENT ABSTRACT 15 8000 PART I, LINE 2: GRANTS AND AWARDS ARE AWARDED AND MONITORED BASED ON A PROGRAM'S BUDGET AND GRANT STIPULATIONS, IF ANY. PROGRAM MANAGERS ARE RESPONSIBLE FOR MONITORING THE USE OF GRANT FUNDS. X 1 1 X X X X X X 0 0 0 0 0 0 0 0 0 THOMAS SERENA CHIEF EXECUTIVE OFFICER 487053 0 0 0 3564 0 23100 0 15140 0 528857 0 0 0 NANCY CHILL SR. VICE PRESIDENT 295039 789 0 0 1239 3 12053 32 21969 59 330300 883 0 0 CHRISTOPHER BLUHM SR. VICE PRESIDENT 225268 4285 0 0 3271 62 8031 153 25468 484 262038 4984 0 0 JEFFREY SPRINGER VP, MARKETING 206067 19225 0 0 1928 180 7285 680 16316 1522 231596 21607 0 0 ALISON KIM VP, RESEARCH & PUBLICATIONS 220469 0 0 0 429 0 9275 0 22028 0 252201 0 0 0 ELLEN SILVER VP, MEETINGS & CONVENTIONS 217739 633 0 0 1106 3 9319 27 22189 65 250353 728 0 0 CHANTAL FREMONT VP, PRACTICE & QUALITY 213813 0 0 0 700 0 7619 0 16735 0 238867 0 0 0 KATHLEEN TEIXEIRA VP, ADVOCACY 9875 195855 0 0 93 1847 413 8192 1057 20971 11438 226865 0 0 JESSICA DUNCAN VP, COMMUNICATIONS 210261 13104 0 0 660 41 7187 448 0 0 218108 13593 0 0 LYNN GRONE VP, ORGANIZATIONAL EFFECTIVENESS 185844 0 0 0 2685 0 8254 0 22028 0 218811 0 0 0 LESLIE HAUVER VP, INFORMATION TECHNOLOGY 193949 0 0 0 955 0 7629 0 7245 0 209778 0 0 0 CELENA NUQUAY VP, CONSTITUENCY & GOVERNANCE 132948 17673 0 0 635 84 6075 808 19443 2585 159101 21150 0 0 MAURA DAVIS SR. DIR EDUCATION 143682 384 0 0 310 1 6840 18 21969 59 172801 462 0 0 SONYA SERRA SR. DIR CLINICAL RESEARCH 141792 0 0 0 686 0 6685 0 22028 0 171191 0 0 0 TIMOTHY SUMMERS SR. DIR FINANCE 120948 8639 0 0 239 17 5578 398 20559 1469 147324 10523 0 0 PART I, LINE 1A THE ASSOCIATION'S PRESIDENT IS PERMITTED TO BRING A COMPANION ON CERTAIN BUSINESS TRIPS FOR THE ASSOCIATION. X 2 49552 0 1 0 PART I, COLUMN (B): ORGANIZATIONS REPORTS NUMBER OF STOCK CONTRIBUTIONS RECEIVED. FORM 990, PART VI, SECTION A, LINE 1A THE INSTITUTE'S GOVERNING BOARD HAS AN EXECUTIVE COMMITTEE, CONSISTING OF THE BOARD OFFICERS, THE PAST PRESIDENT AND THE CHAIR OF THE INSTITUTE'S FOUNDATION FOR DIGESTIVE HEALTH AND NUTRITION. THE EXECUTIVE COMMITTEE HAS THE FOLLOWING DUTIES AND RESPONSIBILITIES: (1) DURING THE INTERVALS BETWEEN THE MEETINGS OF THE GOVERNING BOARD, TO EXERCISE SUCH POWERS AS MAY BE DELEGATED TO IT BY THE GOVERNING BOARD; (2) MAKE RECOMMENDATIONS TO THE GOVERNING BOARD AS TO MATTERS OF CHANGES, EXTENSIONS OR REVISIONS IN THE CORPORATIONS POLICY; (3) TO RECEIVE AND STUDY REPORTS OF SUCH COMMITTEES AS THE GOVERNING BOARD MAY DIRECT; (4) TO ACT AS AN ADVISORY BODY TO THE PRESIDENT; (5) TO KEEP A RECORD OF ITS PROCEEDINGS AND REPORT THE SAME TO THE GOVERNING BOARD AT THE NEXT SUCCEEDING MEETING FOR ITS APPROVAL OR DISAPPROVAL; AND (6) TO HOLD ITS MEETINGS AT SUCH PLACE OR PLACES AS IT MAY FROM TIME TO TIME DETERMINE. IN ADDITION, THE COMMITTEE MAY BE CALLED UPON TO MEET AT ANY TIME BY THE PRESIDENT OF THE FOUNDATION. ALL ACTIONS OF THE EXECUTIVE COMMITTEE SHALL BE SUBMITTED TO THE GOVERNING BOARD FOR RATIFICATION. IN ADDITION, THE EXECUTIVE COMMITTEE SHALL REVIEW AND EVALUATE PERFORMANCE OF EXISTING MEMBERS OF ALL COMMITTEES AND TASK FORCES AND DEVELOP SYSTEMS, POLICIES, AND PROCEDURES TO ASSURE THAT ALL MEMBERSHIP THEREON IS APPROPRIATE TO THE RELEVANT MISSION AND THAT PROSPECTIVE APPOINTMENTS MEET THE NEEDS OF THE ORGANIZATION. THE EXECUTIVE COMMITTEE SHALL OVERSEE SELECTION OF ALL OFFICIAL AWARDS, PRIZES, AND GRANTS; AND SPECIFICALLY TO SELECT THE ANNUAL RECIPIENT OF THE JULIUS FRIEDENWALD MEDAL, WHICH WILL BE PRESENTED TO A MEMBER OF THE AMERICAN GASTROENTEROLOGICAL ASSOCIATION FOR DISTINGUISHED ACHIEVEMENT IN GASTROENTEROLOGY. THE EXECUTIVE COMMITTEE SHALL ALSO (1) ASSESS THE NEED FOR PRINT AND ELECTRONIC PUBLICATIONS AND SERVICES IN THE AREAS OF GASTROENTEROLOGY SCIENCE, CLINICAL PRACTICE, AND EDUCATION, (2) RECOMMEND AND INITIATE PUBLISHING PROJECTS AND ACTIVITIES IN RESPONSE TO THOSE NEEDS, (3) DEVELOP PUBLICATION-RELATED POLICIES FOR APPROVAL BY THE GOVERNING BOARD, AND (4) ENSURE THE QUALITY AND FINANCIAL VIABILITY OF ALL AGA INSTITUTE PUBLICATIONS. FORM 990, PART VI, SECTION A, LINE 6 THE SOLE MEMBER OF THE ORGANIZATION IS AMERICAN GASTROENTEROLOGICAL ASSOCIATION, INC., A RELATED ENTITY EXEMPT FROM FEDERAL INCOME TAX UNDER IRC SECTION 501(C)(6). FORM 990, PART VI, SECTION A, LINE 7A THE INSTITUTE'S GOVERNING BOARD CONSISTS OF TWELVE PERSONS, ELEVEN OF WHICH ARE ELECTED BY THE MEMBER (THE AMERICAN GASTROENTEROLOGICAL ASSOCIATION) AND ONE OF WHICH IS THE CHAIR OF THE INSTITUTE'S AGA RESEARCH FOUNDATION (NOT A SEPARATE ENTITY). FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS PREPARED BY A THIRD PARTY, FROM INFORMATION SUPPLIED BY THE INSTITUTE. AGA MANAGEMENT REVIEWS THE FINAL FORM 990 AND ADDRESSES ANY QUESTIONS PRIOR TO FILING. THE GOVERNING BOARD DOES NOT REVIEW THE FORM 990 PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C THE GOVERNING BOARD MEMBERS ARE REQUIRED TO COMPLETE A CONFLICT OF INTEREST POLICY FORM QUARTERLY TO DISCLOSE ANY CONFLICTS THAT MAY ARISE. FORM 990, PART VI, SECTION B, LINE 15 THE EXECUTIVE COMPENSATION COMMITTEE MEETS ANNUALLY TO REVIEW AND APPROVE COMPENSATION OF TOP MANAGEMENT OFFICIALS. AN INDEPENDENT CONSULTANT IS USED TO PROVIDE COMPARABLE SURVEY DATA TO HELP SET COMPENSATION LEVELS FOR THE CEO AND SENIOR POSITIONS. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY AVAILABLE UPON REQUEST. FORM 990, PART IX, LINE 11G CONTRACTORS: PROGRAM SERVICE EXPENSES 2,626,321. MANAGEMENT AND GENERAL EXPENSES 216,867. FUNDRAISING EXPENSES 33,402. TOTAL EXPENSES 2,876,590. PROFESSIONAL FEES: PROGRAM SERVICE EXPENSES 209,494. MANAGEMENT AND GENERAL EXPENSES 43,341. FUNDRAISING EXPENSES 75,000. TOTAL EXPENSES 327,835. BENEFITS ADMINISTRATION FEES: PROGRAM SERVICE EXPENSES 0. MANAGEMENT AND GENERAL EXPENSES 7,981. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 7,981. PAYROLL PROCESSING FEES: PROGRAM SERVICE EXPENSES 0. MANAGEMENT AND GENERAL EXPENSES 49,534. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 49,534. DESIGN/GRAPHIC: PROGRAM SERVICE EXPENSES 62,662. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 62,662. MED. EDUC. COMPANY: PROGRAM SERVICE EXPENSES 2,402,574. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 2,402,574. FORM 990, PART XI, LINE 9: GRANT RECOVERIES 146,925. CHANGE IN VALUE OF DEFERRED COMPENSATION INVESTMENTS -11,022. AMERICAN GASTROENTEROLOGICAL ASSOCIATION INC (AGA) 4930 DEL RAY AVENUE BETHESDA MD 20814 202986410 PROFESSIONAL MEMBERSHIP ASSOCIATION DE 501(C)(6) N/A 0 AGA POLITICAL ACTION COMMITTEE 4930 DEL RAY AVENUE BETHESDA MD 20814 204759482 POLITICAL ACTION COMMITTEE MD 527 AGA 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 1 0 0 AMERICAN GASTROENTEROLOGICAL ASSOCIATION INC (AGA) J 111425 LEASE CONTRACT AMERICAN GASTROENTEROLOGICAL ASSOCIATION INC (AGA) O 1125188 TIME RECORD AMERICAN GASTROENTEROLOGICAL ASSOCIATION INC (AGA) Q 1890535 FMF